News 2024年 05月 10日 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 2024年 01月 24日 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
News 2023年 11月 21日 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 2023年 10月 04日 US health agency links up with the Paul Scherrer Institute Researchers from the Paul Scherrer Institute are working on an efficient method of mapping the brain of a mouse. As part of the BRAIN Initiative,...
Aktuell 2023年 11月 21日 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 2023年 09月 13日 HAYA Therapeutics triumphs at the 13th TOP 100 Swiss Startup Award Western Switzerland’s burgeoning start-up scene witnessed another remarkable year of innovation and growth as Haya Therapeutics won the first pla...
News 2023年 11月 02日 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
News 2023年 09月 29日 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Actualités 2022年 10月 06日 Le Biopôle grandit encore avec la construction de trois nouveaux bâtiments Biopôle a annoncé que la SICAV Edmond de Rothschild Real Estate investira dans la construction de trois nouveaux bâtiments sur le campus d’Epalin...
News 2017年 12月 18日 New conformity assessment procedure in the United Arab Emirates The new conformity assessment covers restrictions on the use of hazardous ingredients in electronic and electrical goods (RoHS: Restriction of Ha...
News 2023年 05月 17日 Geneva start-ups Fluosphera, Kylys Aesthetics and Consulto receive FIF support The Fondation Genevoise pour l’Innovation Technologique (Fongit) has announced the latest recipients of the Fongit Innovation Fund (FIF) support....
News 2021年 08月 10日 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
News 2023年 03月 22日 FIF funding awarded to three innovative Geneva-based projects Geneva-based start-ups Plair, Endotelix, and Dr. Beat Walpoth have received the Fongit Innovation Fund (FIF) for their remarkable innovations.
News 2021年 04月 30日 ADC Therapeutics receives FDA approval for its lymphoma cancer treatment ZYNLONTA Oncology biotechnology company ADC Therapeutics has received the first FDA approval for ZYNLONTA, its lead drug candidate for the treatment of ad...
Press Release 2021年 01月 11日 Swiss start-ups at CES 2021 Switzerland will be participating in the Consumer Electronics Show (CES) for the third time in a row. From January 11-14, 2021, Switzerland Globa...
News 2021年 01月 19日 Ticino Ebola drug receives US authorization The United States Food and Drug Administration (FDA) has authorized an Ebola drug developed by two laboratories based in the Greater Zurich Area....
News 2022年 10月 06日 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...